UK markets closed

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
46.400-1.250 (-2.62%)
At close: 04:08PM HKT
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
4,081,402
3,388,478
1,688,886
1,013,805
630,592
Depreciation & amortisation
-
481,783
303,009
221,365
143,770
Stock-based compensation
-
531,923
276,370
203,938
128,374
Change in working capital
-
-963,326
-367,063
-216,065
-245,737
Inventory
-
-783,185
-704,522
-94,005
-95,683
Other working capital
-1,043,313
-3,091,856
-4,143,504
-2,026,576
-1,068,876
Other non-cash items
-
-45,127
-74,946
-63,272
-79,126
Net cash provided by operating activities
4,091,171
3,431,258
1,881,276
1,208,079
761,607
Cash flows from investing activities
Investments in property, plant and equipment
-5,134,484
-6,523,114
-6,024,780
-3,234,655
-1,830,483
Acquisitions, net
-145,366
-2,535,130
-155,239
-300,821
-
Purchases of investments
-21,004,870
-59,300,120
-20,353,451
-4,641,602
-1,057,205
Sales/maturities of investments
21,744,903
58,243,899
19,250,078
3,913,606
2,334,795
Other investing activities
45,657
313,947
-28,011
-331,721
56,534
Net cash used for investing activities
-4,223,055
-9,601,670
-7,216,283
-4,493,930
-416,074
Net change in cash
-3,146,422
1,907,545
890,239
2,121,101
3,580,514
Cash at beginning of period
11,281,712
7,095,735
6,205,496
4,084,395
503,881
Cash at end of period
7,924,809
9,003,280
7,095,735
6,205,496
4,084,395
Free cash flow
Operating cash flow
4,091,171
3,431,258
1,881,276
1,208,079
761,607
Capital expenditure
-5,134,484
-6,523,114
-6,024,780
-3,234,655
-1,830,483
Free cash flow
-1,043,313
-3,091,856
-4,143,504
-2,026,576
-1,068,876